Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 190.26M P/E 96.73 EPS this Y - Ern Qtrly Grth -19.90%
Income 2.3M Forward P/E - EPS next Y - 50D Avg Chg 1.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 3.00%
Dividend N/A Price/Book 483.64 EPS next 5Y - 52W High Chg -
Recommedations - Quick Ratio 0.01 Shares Outstanding 6.65M 52W Low Chg 5.00%
Insider Own 35.82% ROA - Shares Float 4.25M Beta -
Inst Own 65.12% ROE - Shares Shorted/Prior 512/148 Price 10.64
Gross Margin - Profit Margin - Avg. Volume 9,788 Target Price -
Oper. Margin - Earnings Date - Volume 3,414 Change 0.00%
About TenX Keane Acquisition

TenX Keane Acquisition does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on target businesses operating in Asia, excluding companies located or operating in mainland China, Hong Kong, or Macau. TenX Keane Acquisition was incorporated in 2021 and is based in New York, New York.

TENK Chatroom

User Image TwongStocks Posted - 1 day ago

$TENK extended their business combination deadline from Jun 18 to July 18th. This is the 3rd such monthly extension. Deadline was previously extended from Apr 18 to May 18 and then from May 18 to Jun 18. https://www.sec.gov/ix?doc=/Archives/edgar/data/1851484/000149315224024236/form8-k.htm The deadline can be extended monthly, all the way through Nov 18th.

User Image Stock_Titan Posted - 1 month ago

$CTXR $TENK Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2024 Financial Results and Provides Business Update https://www.stocktitan.net/news/CTXR/citius-pharmaceuticals-inc-reports-fiscal-second-quarter-2024-hrg236qogm04.html

User Image TickerDD_com Posted - 1 month ago

From 5/3/2024, looking back across 18 Month-Ends for TENK, Percentage Change of Average Monthly Price had while Percentage Change of Average Monthly Volume had More Positives (94%) $TENK #TENK #TENKStock #TickerDD https://www.youtube.com/watch?v=JFdrWR07BIU

User Image TwongStocks Posted - 1 month ago

$TENK filed their amended S-4, for the merger with Citius Oncology: https://www.sec.gov/ix?doc=/Archives/edgar/data/1851484/000149315224017749/forms-4a.htm It's Friday, so I don't have a chance to view this in-depth. I did notice that they still have not set a date for their shareholder meeting to approve the merger. I'll update this post after I get a chance to review it more in-depth, if I see anything noteworthy. Here is the projected share count of the NewCo. The first table assumes no further redemptions of TENK stock. The second assumes 50% redemptions. The last table assumes 100% redemptions. $CTXR

User Image TwongStocks Posted - 04/29/24

$TENK Deadline to extend business combination was extended from Apr 18 to May 18. As part of the extension, $CTXR (as designated by TENK's sponsor) deposited $66,667 into TENK's trust account. TENK issued a no-interest promissory note for the same amount to CTXR. If the parties can't close a business combination by May 18, the deadline can be extended to June 18, pendng another deposit of $66,667 to TENK's trust account. https://www.sec.gov/ix?doc=/Archives/edgar/data/0001851484/000149315224017024/form8-k.htm

User Image jjgrey05 Posted - 04/25/24

$TENK should buy out $NAOV as well

User Image TwongStocks Posted - 2 months ago

$CTXR $TENK 10-K filed. https://www.sec.gov/ix?doc=/Archives/edgar/data/0001851484/000149315224014850/form10-k.htm They currently have 6.65m shares as of Apr 16th. As of Dec 31, they had $72.5m in their trust account. However, after some redemptions in January, their trust account was reduced by $24.9m. Which leaves them with about $47.6m in the trust account. Don't really see anything about a timeline for the merger. Next deadline for them to close is is Apr 18, but they have shareholder permission to extend that deadline, all the way through Nov 18.

User Image Stock_Titan Posted - 4 months ago

$CTXR $TENK Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2024 Financial Results and Provides Business Update https://www.stocktitan.net/news/CTXR/citius-pharmaceuticals-inc-reports-fiscal-first-quarter-2024-9hhhg0ta6fed.html

User Image TickerDD_com Posted - 4 months ago

From 2/6/2024, looking back across 15 Month-Ends for TENK, Percentage Change of Average Monthly Price had while Percentage Change of Average Monthly Volume had All Positives (100%) $TENK #TENK #TENKStock #TickerDD #TENKPrice https://www.youtube.com/watch?v=TUw7XBLeLgk

User Image TwongStocks Posted - 5 months ago

$TENK Looks like 2,287,923 have been redeemed. Trust account reduced by $25m.

User Image Last10K Posted - 5 months ago

$TENK just filed with the SEC a New Agreement, a New Financial Obligation, a Bylaw Change, a Vote of Security Holders and a Financial Exhibit https://last10k.com/sec-filings/TENK/0001493152-24-002896.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=TENK

User Image risenhoover Posted - 5 months ago

$TENK / TenX Keane Acquisition files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2024 TenX Kea https://fintel.io/doc/sec-tenx-keane-acquisition-1851484-8k-2024-january-18-19740-1566?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image TwongStocks Posted - 5 months ago

$TENK Shareholder meeting this morning. TenX Keane shareholders voted to approve the extension proposal. As a result, TenX will extend their deadline to consummate a business deal with Citius Oncology (currently a subsidiary of $CTXR). Deadline extended from January 18, 2024 to April 18, 2024. If additional time is needed, they can do 7 monthly extensions through November 18, 2024. TenX shareholders were afforded the opportunity to ask questions, but no questions were brought forward. SEC filing to follow with the official meeting results. 8-K due within 4 business days of today's meeting.

User Image risenhoover Posted - 5 months ago

$TENK / TenX Keane Acquisition files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2024 TenX Kea https://fintel.io/doc/sec-tenx-keane-acquisition-1851484-8k-2024-january-10-19732-9697?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image Last10K Posted - 5 months ago

$TENK just filed with the SEC a Financial Exhibit https://last10k.com/sec-filings/TENK/0001493152-24-001958.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=TENK

User Image MarketForecasting Posted - 5 months ago

$CTXR $TENK how is that good news , it’s more delays , something that hasn’t been seen before .

User Image FreeRunner Posted - 5 months ago

$CTXR $TENK General meeting of Shareholders on January 17, 2024, at 9:30 a.m. Eastern Standard Time : THE BOARD UNANIMOUSLY RECOMMENDS A VOTE “FOR” THE EXTENSION AMENDMENT PROPOSAL, THE AUDITOR RATIFICATION PROPOSAL, AND IF PRESENTED, THE ADJOURNMENT PROPOSAL https://www.sec.gov/Archives/edgar/data/1851484/000149315224001720/formdef14a.htm

User Image risenhoover Posted - 5 months ago

$TENK / TenX Keane Acquisition files form DEF 14A https://fintel.io/doc/sec-tenx-keane-acquisition-1851484-def-14a-2024-january-08-19730-8358?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image risenhoover Posted - 12/28/23

$TENK / TenX Keane Acquisition files form PRE 14A https://fintel.io/doc/sec-tenx-keane-acquisition-1851484-pre-14a-2023-december-28-19719-8434?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image MomentumDweller Posted - 6 months ago

Make sure it's on your watchlist 💎 $NYXH $NRSN $TENK $BRFH ..

User Image Last10K Posted - 11/20/23

$TENK just filed a 10-Q Quarterly Report with 5 financial statements and 23 disclosures: https://last10k.com/sec-filings/tenk/0001493152-23-042170.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=10KQ2040F&utm_term=tenk

User Image EarningsInsider Posted - 11/20/23

TenX Keane Acquisition Files SEC Form 10-Q $TENK https://www.marketbeat.com/stocks/NASDAQ/TENK/sec-filings/

User Image risenhoover Posted - 11/20/23

$TENK / TenX Keane Acquisition files form 10-Q https://fintel.io/doc/sec-tenx-keane-acquisition-1851484-10q-2023-november-20-19681-3342?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image TwongStocks Posted - 7 months ago

$TENK ER will be late. Unable to file their 10-Q by the Nov 14th deadline. Will file by Nov 20th. https://www.sec.gov/Archives/edgar/data/1851484/000149315223041244/formnt10-q.htm

User Image TwongStocks Posted - 7 months ago

$TENK S-4 filing to register the shares that will be issued to $CTXR in conjunction with the business combination of TenK Keane & Citius Oncology. Much of it is still redacted, but we have the following tidbits: -The NewCo BoD & management will consist primarily of CTXR personnel. NewCo's board will essentially be CTXR's current Board + Joel Mayersohn. Leonard Mazur (CEO), Jaime Bartushak (CFO), & Myron Czuczman (CMO) will hold similar roles in both CTXR & NewCo. -Post merger, NewCo is expected to have 71m-78m shares and $6m-$75m in cash. Final numbers depend on the number of TenX shares that get redeemed prior to merger. Up to 6.6m TenX shares are subject to redemption. -"Additionally, Citius Pharma may distribute up to 10% of the shares of New Citius Oncology Common Stock it receives in the Merger to its stockholders and such distributed shares would not be subject to restrictions. " ^Sounds like CTXR can distribute up to 6.75m shares to shareholders. Details-->https://www.reddit.com/r/CTXR/comments/17un4ae/tenx_keane_filed_the_initial_s4_related_to_their/?utm_source=share&utm_medium=web2x&context=3

User Image EarningsInsider Posted - 7 months ago

TenX Keane Acquisition Files SEC Form S-4 $TENK https://www.marketbeat.com/stocks/NASDAQ/TENK/sec-filings/

User Image risenhoover Posted - 7 months ago

$TENK / TenX Keane Acquisition files form S-4 https://fintel.io/doc/sec-tenx-keane-acquisition-1851484-s4-2023-november-13-19674-5587?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image TOM1212 Posted - 7 months ago

$CTXR Let’s all hold our $TENK shares so we can see how little influence we have when they drop.

User Image Temptaz Posted - 10/27/23

$TENK as much as I want this to work out I foresee huge sells as soon as any of these shares are unlocked.

User Image TwongStocks Posted - 10/26/23

$CTXR When they originally proposed spinning off Lymphir, i assumed they meant a traditional spinoff with IPO. CTXR shareholders would get equity in the spinoff. The IPO would raise cash for the NewCo. But that would had netted CTXR nothing in return. With the $TENK deal, yes CTXR has to give up $10m. But in return they will have 67.5m shares in the NewCo. The equity gives them some flexibility that they wouldn't have in a traditional spinoff+IPO. Even if the NewCo shares tank, 67.5m shares should allow CTXR to recoup some value. If NewCo falls post-merger, CTXR should still be able to recoup that $10m if they sell enough equity. Maybe even the value of the original $40m upfront. If NewCo can hold value or rise, they might even be able to sell some and still have enough left over to redistribute to CTXR shareholders. That's where the value in this deal lies. The 67.5m equity stake in NewCo.